Artificial Intelligence (AI) in Medical Imaging Market is predicted to reach USD 21.90 billion at a CAGR of 38.9% during the forecast period 2022 to 2030.

Market Research Future (MRFR) has published a cooked research report on the “global artificial intelligence (AI) in medical imaging market” that contains the information from 2019 to 2030. 

The AI in medical imaging market is accounted to register a CAGR of 38.9% during the forecast period of 2023 to 2030.

MRFR recognizes the following companies as the key players in the global artificial intelligence (AI) in medical imaging market— GE Healthcare (US), Canon Medical Systems Corporation (Japan), FUJIFILM Visualsonics, Inc. (Canada), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), IBM Corporation (US), Butterfly Network (US), AGFA HealthCare (US), Arterys (US), 3M (US), and others.

Global AI in Medical Imaging Market Highlights

The global AI in medical imaging market is estimated to register a CAGR of 38.9% during the forecast period and is projected to reach USD 21.90 billion by 2030.

The growth of the market is positively contributing owing to factors including the rising number of AI-powered medical imaging start-ups, increasing funding and investment for AI in medical imaging, and rising incidences of chronic diseases. However, shortages in skilled professionals is restricting the market's growth. Moreover, technological advancements in AI in medical imaging and the increasing adoption of AI medical imaging solutions via healthcare providers are creating huge opportunities for the market during the forecast period.

Access full report details on AI in Medical Imaging Market Growth

Segment Analysis

The global AI in medical imaging market has been segmented based on technology, component, modalities, indication, application, and end user.

On the basis of technology, the market is segmented into deep learning, natural language processing (NLP), and others. The deep learning segment held the largest market in 2022, due to benefits such as diagnosing with accuracy and early detection. While natural language processing is expected to grow the fastest during the forecast period.

Based on component, the global AI in the medical imaging market has been segmented into solutions and services. The solution segment held the largest market share in 2022 owing to increasing product launches, rising investment, and funding to advance existing products, and an increasing number of start-ups associated with AI in medical imaging solutions.

The global AI in the medical imaging market, based on modalities, has been segmented into computed tomography (CT), x-rays, magnetic resonance imaging (MRI), ultrasound, and others. The CT segment held the largest segment market share in the base year, i.e., 2022, due to having an advantage in automation for imaging along with increasing investment in the development of AI in CT medical imaging.

The global AI in the medical imaging market has segmented on the basis indication into oncology, neurology, cardiology, orthopaedic, gynaecology, and others. The oncology segment held the largest market share in 2022, and neurology is the fastest-growing segment during the forecast period. The increasing prevalence of cancer worldwide are driving the segment growth. As per the World Cancer Research Fund International, there were 9.3 million men diagnosed with cancer and 8.8 million in women.

Based on application, the global AI in the medical imaging market has been segmented into clinical decision support, computer-aided diagnosis, and computer-aided detection. The computer-aided diagnosis segment held the largest market share in 2022, owing to the wide range of computer-aided diagnosis applications such as better diagnosis, less waiting time, less manual work, improved patient prognosis, and lower errors.

On the basis of end user, the market is segmented into diagnostic centers, hospitals & clinics, and others. The diagnostic centres segment held the largest market with a market share in 2022 and is the fastest-growing segment during the forecast period. This is due to the increasing prevalence of chronic diseases such as diabetes and cancer. AI based medical imaging has immense potential in improving diabetes diagnostics. As per the Diabetes Atlas 2022, there are 476 million indigenous people in 90 countries, and 10% of them suffer from type II diabetes. Moreover, by utilizing a fully automated AI deep learning model, physicians are able to identify early signs of type II diabetes.

Regional Analysis

The global AI in medical imaging market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe AI in medical imaging market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The AI in medical imaging market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World AI in medical imaging market comprises of Middle East, Africa, and Latin America.

The North America AI in medical imaging market held the largest market share in 2022 due to factors including the increasing prevalence of chronic diseases including arthritis, cancer, and heart diseases and the presence of several major market players. According to the Centers for Disease Control and Prevention, 695,000 people died from heart disease in 2021. Furthermore, AI in the imaging of cardiovascular diagnosis can provide a comprehensive description of the patient's cardiovascular health aiding in timely and accurate diagnosis.

Furthermore, Europe AI in the medical imaging market shows significant growth during the forecast period. This is due to the high adoption of technology-based, AI-based medical imaging products and the increasing prevalence of neurological diseases.

Furthermore, the Asia-Pacific market's growth is attributed to factors like the rising geriatric population, increasing adoption of sedentary lifestyles and physical inactivity, and increasing prevalence of chronic diseases. Moreover, companies are accelerating commercialization in order to meet the demand of the end user. For instance, in September 2019, Shukun Technology (China) accelerated the commercialization of its technologies in order to assist in cardiovascular disease diagnosis in 42 cities in China.

Additionally, the Middle East, Africa, and Latin America regions comprised the rest of the world. The region accounted for the lowest market share in the AI in medical imaging market due to a lack of awareness associated with AI in medical imaging and the slow adoption of technology-based products. However, the Middle East region is growth in the region by taking substantial efforts to adopt cutting edge technologies and improve healthcare infrastructure in the country. For instance, there are AI-powered start-ups based in Israel, such as Ibex and AIdoc, focusing on developing AI in medical imaging and raising funding, which will create lucrative growth opportunities.

Key Findings of the Study

• The global AI in medical imaging market is accounted to reach USD 21.90 billion by 2030, at a CAGR of 38.9% during the forecast period.


• The Europe region shows significant growth during the forecast period due to the adoption of technologically advanced and favorable government support.


• Based on modalities, the computed tomography (CT) segment held the largest market share in 2022, with an approximate market share of 40% to 45%.


• GE Healthcare (US), Canon Medical Systems Corporation (Japan), FUJIFILM Visualsonics, Inc. (Canada), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), IBM Corporation (US), Butterfly Network (US), AGFA HealthCare (US), Arterys (US), 3M (US), and others are the key market players.